イソフラボンサプリメントの世界市場：2023年～2030年

概要

イソフラボンサプリメントの世界市場は、2022年に7億2,120万米ドルに達し、2023年～2030年の予測期間中にCAGR 5.1%で成長し、2030年には10億7,360万米ドルに達すると予測されています。

天然素材や植物由来の製品を重視する傾向が強まる中、消費者は合成サプリメントに代わるものを求めています。大豆やその他の豆類に含まれる天然化合物であるイソフラボンはこの動向に合致しており、イソフラボンサプリメントの需要増につながっています。イソフラボンは、特に更年期障害の管理、心臓の健康促進、特定のがんのリスク低減など、健康上の利点があるとの認識が消費者の間で高まっています。

2021年4月、韓国のPulmuone社は更年期障害の緩和を目的とした大豆とホップエキスのサプリメントを発売しました。同社は、ホップ抽出物と黒大豆由来のイソフラボンが、更年期に分泌量が減少し更年期障害の原因となる女性ホルモンのエストロゲンと化学構造が一致するため、有益であることを明らかにしました。

大豆由来のイソフラボンサプリメントは、ゲニステインやダイゼインといった天然由来のイソフラボンを豊富に含むため、市場シェアの半分以上を占めています。同様に、北米はイソフラボンサプリメント市場を独占しており、高い消費者意識、強固な調査インフラ、自然健康法への関心の高まりが相まって、最大の市場シェアを獲得しています。

ダイナミクス

更年期症状の有病率の上昇

世界人口の高齢化に伴い、更年期を迎える女性が増加しています。国立医学図書館によると、2030年までに世界中で12億人の更年期・閉経後女性が存在し、そのうち毎年4,700万人が更年期を迎えると予測されています。更年期を経験する女性の人口が増えるにつれ、関連する症状の管理に役立つ製品の需要が高まっています。

大豆やその他の豆類に含まれる植物由来の化合物であるイソフラボンは、体内でエストロゲンの作用を模倣し、こうした症状の緩和に関係しています。イソフラボンのサプリメントが更年期障害の緩和に役立つという認識が広まるにつれ、そのような製品に対する需要も高まっています。さらに、世界の高齢化の進展に伴い、更年期を経験する女性の数は増加傾向にあり、市場の拡大をさらに後押ししています。

健康効果に対する意識の高まり

イソフラボンは、主に大豆やその他の豆類に含まれる天然由来の化合物です。米国国立医学図書館によると、Cancellieriらは、Kupperman Menopause Indexに基づき、レッドクローバーと大豆由来のイソフラボン72mgからなるハーブサプリメントを6ヵ月間摂取したところ、ほてりが劇的に軽減したことを明らかにしました。イソフラボンは、更年期症状の緩和とともに、特に骨粗鬆症のリスクが高い閉経後の女性の骨の健康を保護する効果があります。

イソフラボンは、骨代謝を調整し、骨形成を促進することで、骨密度を維持し、骨折のリスクを軽減します。また、イソフラボンは、LDLコレステロール値を低下させ、HDLコレステロール値を上昇させることで、脂質プロファイルを改善する能力など、心血管系への潜在的な有益性が研究されています。イソフラボンサプリメントの潜在的な効能が消費者に知られるようになるにつれ、イソフラボンサプリメントに対する需要も増加しています。

規制上の課題

規制当局は、イソフラボンサプリメントの販売や表示について、特に健康強調表示や安全性に関する規制やガイドラインを課す可能性があります。こうした規制の遵守はコスト増につながり、メーカーの製品宣伝能力を制限するため、予測期間中の市場拡大を妨げる可能性があります。

2020年1月、栄養補助食品と乳児用調製粉乳の届出規制を遵守するため、ポーランドの首席衛生検査官は企業の「監督改善」を目的とした届出制度の実施を発表しました。2019年初め、ポーランドは食品サプリメントに含まれる物質の最大量の規制を開始しました。そこで当局は、イソフラボン（大豆およびその他）、アロエベラ、ベータアラニン製剤の使用ガイドラインと制限を定めました。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 更年期症状の有病率の上昇
    • 健康効果に対する意識の高まり
  • 抑制要因
    • 規制上の課題
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• ロシア・ウクライナ戦争の影響分析
• DMIの見解

第6章 COVID-19分析

第7章 供給源別

• 大豆
• ひよこ豆
• レッドクローバー
• その他

第8章 用途別

• 食品・飲料
• 化粧品
• 栄養補助食品
• 医薬品
• その他

第9章 流通チャネル別

• ハイパーマーケット／スーパーマーケット
• ドラッグストア・薬局
• eコマース
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • ロシア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第12章 企業プロファイル

• NOW Health Group, Inc.
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Solgar Inc.
• Swanson
• Life Extension
• GNC Holdings, LLC
• Pure Encapsulations
• Bluebonnet Nutrition
• Douglas Laboratories
• Jabs Biotech Pvt. Ltd.
• ST Century HealthCare, Inc.

第13章 付録

Overview

Global Isoflavone Supplements Market reached US$ 721.2 million in 2022 and is expected to reach US$ 1.073.6 million by 2030, growing with a CAGR of 5.1% during the forecast period 2023-2030.

With a growing emphasis on natural and plant-based products, consumers are seeking alternatives to synthetic supplements. Isoflavones, which are naturally occurring compounds found in soybeans and other legumes, fit into this trend, leading to increased demand for isoflavone supplements. Consumers are becoming increasingly aware of the potential health benefits associated with isoflavones, particularly in managing menopausal symptoms, promoting heart health, and potentially reducing the risk of certain cancers.

In April 2021, Pulmuone, a South Korean company, launched a soybean and hop extract supplement for alleviating menopausal symptoms. The company clarified that isoflavones derived from hop extracts and black soybeans were beneficial because they had a chemical structure with the female hormone estrogen, whose production declines during menopause and causes menopausal symptoms.

The soy-based isoflavone supplements account for over half of the market share due to their rich content of naturally occurring isoflavones, such as genistein and daidzein. Similarly, North America dominates the isoflavone supplements market, capturing the largest market share due to a combination of high consumer awareness, robust research infrastructure, and a growing interest in natural health solutions.

Dynamics

Rising Prevalence of Menopausal Symptoms

As the global population ages, there is a growing number of women entering menopause. According to the National Library of Medicine, it is predicted that by 2030, there will be 1.2 billion menopausal and postmenopausal women worldwide, with 47 million of them joining the population annually. With a larger population of women experiencing menopause, there is a greater demand for products that can help manage associated symptoms.

Isoflavones, plant-derived compounds found in soy and other legumes, mimic the effects of estrogen in the body and have been associated with alleviating these symptoms. As awareness of the potential benefits of isoflavone supplements in managing menopausal symptoms grows, so does demand for such products. Additionally, with an increasing aging population worldwide, the number of women experiencing menopause is on the rise, further propelling the market expansion.

Growing Awareness about Health Benefits

Isoflavones are naturally occurring compounds found predominantly in soybeans and other legumes. According to the National Library of Medicine, Cancellieri et found that Based on the Kupperman Menopause Index, hot flashes were dramatically reduced after six months of consuming a herbal supplement comprising 72 mg of isoflavones from red clover and soybeans. Along with menopausal symptom relief, isoflavones have a protective effect on bone health, particularly in postmenopausal women who are at increased risk of osteoporosis.

Isoflavones help maintain bone density and reduce the risk of fractures by modulating bone metabolism and promoting bone formation. Also, isoflavones have been studied for their potential cardiovascular benefits, including their ability to improve lipid profiles by reducing LDL cholesterol levels and increasing HDL cholesterol levels. As consumers become aware of the potential benefits of isoflavone supplements, there is a corresponding increase in demand for these products.

Regulatory Challenges

Regulatory agencies may impose restrictions or guidelines on the marketing and labeling of isoflavone supplements, particularly regarding health claims and safety concerns. Compliance with these regulations can increase costs and limit the ability of manufacturers to promote their products, potentially hindering market expansion in the forecast period.

In January 2020, to comply with notification regulations for dietary supplements and infant formulas, Poland's Chief Sanitary Inspectorate announced to implementation a notification system aimed at "improving supervision" of firms. At the beginning of 2019, Poland started imposing maximum amounts on substances found in food supplements. There, authorities established usage guidelines and limitations for isoflavones (soy and other), aloe vera, and beta-alanine preparations.

Segment Analysis

The global isoflavone supplements market is segmented based on source, application, distribution channel and region.

Abundance of Isoflavones in Soybeans

Soybeans are a rich source of isoflavones, a type of phytoestrogen. For instance, about 3.5 mg of isoflavones are linked to every gram of soy protein found in soybeans and conventional soy foods. As a result, roughly 25 mg of isoflavones are present in one serving of classic soy food, such as 100 g of tofu or 250 mL of soymilk. These compounds are known for potential health benefits, including reducing the risk of certain chronic diseases such as heart disease and osteoporosis and alleviating menopausal symptoms. Due to this natural abundance, soy has become a primary ingredient in many isoflavone supplements.

In October 2023, Pharmalinea introduced an advanced whole-body menopause supplement. According to Maja Oresnik, Science & Research Director, the new supplement contains Soy isoflavones (Qsoy), resveratrol (Qratrol), and vitamin B6, which has been clinically demonstrated to affect phytoestrogen activity, improve cerebral blood flow and vasodilation, enhance insulin sensitivity and cognitive function, slow down the loss of bone mineral density, and lessen chronic pain.

Geographical Penetration

Growing Awareness about Isoflavone Supplements in North America

There is a growing awareness and interest among consumers in North America regarding the health benefits of isoflavones, particularly in managing conditions such as menopausal symptoms and promoting heart health. According to the National Library of Medicine, every year, about 1.3 million women in the US experience menopause. Isoflavone supplements are often utilized to alleviate menopausal symptoms, providing relief to women experiencing discomfort during this transitional phase of life.

Additionally, North America boasts a well-established dietary supplement industry supported by robust distribution channels and widespread availability of various health products, including isoflavone supplements. The accessibility of these supplements through pharmacies, health food stores, online retailers, and other outlets further contributes to the market's dominance in the region.

COVID-19 Impact Analysis

The COVID-19 pandemic led to widespread disruptions in global supply chains, affecting the production and distribution of various goods, including dietary supplements. Restrictions on movement, lockdown measures, and workforce shortages disrupted the supply of raw materials and manufacturing processes for isoflavone supplements. This resulted in delays in production, shortages in supply, and increased costs for manufacturers, impacting the availability of isoflavone supplements in the market.

However, the pandemic prompted a shift in consumer priorities towards health and wellness. With heightened awareness of immune health and overall well-being, there was increased interest in dietary supplements, including those containing isoflavones. Consumers sought products that could potentially support their immune systems and help manage stress and anxiety during uncertain times. This shift in consumer behavior led to a surge in demand for isoflavone supplements, particularly those marketed for their potential health benefits.

Russia-Ukraine War Impact Analysis

The conflict between Russia and Ukraine disrupted global supply chains, affecting the transportation of goods and raw materials. Ukraine is a significant producer of soybeans, a primary source of isoflavones used in supplements. The disruptions in soybean production and export from Ukraine led to shortages or delays in the availability of raw materials for isoflavone supplements, thereby affecting the supply chain and potentially leading to price fluctuations in the market.

By Source

• Soy
• Chickpea
• Red Clover
• Others

By Application

• Food & Beverage
• Cosmetics
• Nutraceuticals
• Pharmaceuticals
• Others

By Distribution Channel

• Hypermarkets/Supermarkets
• Drug Stores & Pharmacies
• E-Commerce
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
• Middle East and Africa

Key Developments

• In October 2023, Nutravita, a supplement company, released a new line to help women through the menopausal phase of life with a choice of supplements that successfully address the most prevalent symptoms in honor of 'Menopause Awareness Month'. It contains soy isoflavones, which are phytoestrogen chemicals and a natural substitute for hormone replacement treatment, in addition to essential minerals that support menopause.
• In February 2023, Pro360, the nutraceutical brand of GMN Group of Companies, launched the FemCare+ and HPHF (High Protein High Fibre) product lines. These products are designed to provide both men and women with a variety of advantages to enhance their lifestyles. Among the enriched, natural ingredients used in the FemCare+ collection are Shatavari, Myo-Inositol, Black Cohosh, Evening Primrose, and Soy Isoflavones.
• In November 2021, Otsuka Pharmaceutical Co., Ltd., launched tocoelle, a supplement to support women bothered by pre-menstrual fluctuations. It provides four essential elements: calcium, which is frequently deficient in daily diets; equol, which is made from soy isoflavones; and vitamin E (Y-tocopherol and Y-tocotrienol), which is found in soy oil.
• In March 2023, Otsuka Pharmaceutical Co., Ltd. (Otsuka) announced the launch of launch of a new version of EQUELLE gelee, an extension of the EQUELLE brand of supplements promoting women's health and beauty. It has 3.2 mg of soy isoflavones (aglycone), 2,500 mg of collagen peptides, and 5 mg of S-equol.

Competitive Landscape

The major global players in the market include NOW Health Group, Inc., Solgar Inc., Swanson, Life Extension, GNC Holdings, LLC, Pure Encapsulations, Bluebonnet Nutrition, Douglas Laboratories, Jabs Biotech Pvt. Ltd., 21ST Century HealthCare, Inc.

Why Purchase the Report?

• To visualize the global isoflavone supplements market segmentation based on source, application, distribution channel, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of isoflavone supplements at the market with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global isoflavone supplements market report would provide approximately 62 tables, 56 figures, and 186 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1.Methodology and Scope

• 1.1.Research Methodology
• 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

• 3.1.Snippet by Source
• 3.2.Snippet by Application
• 3.3.Snippet by Distribution Channel
• 3.4.Snippet by Region

4.Dynamics

• 4.1.Impacting Factors
  • 4.1.1.Drivers
    • 4.1.1.1.Rising Prevalence of Menopausal Symptoms
    • 4.1.1.2.Growing Awareness about Health Benefits
  • 4.1.2.Restraints
    • 4.1.2.1.Regulatory Challenges
  • 4.1.3.Opportunity
  • 4.1.4.Impact Analysis

5.Industry Analysis

• 5.1.Porter's Five Force Analysis
• 5.2.Supply Chain Analysis
• 5.3.Pricing Analysis
• 5.4.Regulatory Analysis
• 5.5.Russia-Ukraine War Impact Analysis
• 5.6.DMI Opinion

6.COVID-19 Analysis

• 6.1.Analysis of COVID-19
  • 6.1.1.Scenario Before COVID
  • 6.1.2.Scenario During COVID
  • 6.1.3.Scenario Post COVID
• 6.2.Pricing Dynamics Amid COVID-19
• 6.3.Demand-Supply Spectrum
• 6.4.Government Initiatives Related to the Market During Pandemic
• 6.5.Manufacturers Strategic Initiatives
• 6.6.Conclusion

7.By Source

• 7.1.Introduction
  • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 7.1.2.Market Attractiveness Index, By Source
• 7.2.Soy*
  • 7.2.1.Introduction
  • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3.Chickpea
• 7.4.Red Clover
• 7.5.Others

8.By Application

• 8.1.Introduction
  • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
• 8.2.Food & Beverage*
  • 8.2.1.Introduction
  • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3.Cosmetics
• 8.4.Nutraceuticals
• 8.5.Pharmaceuticals
• 8.6.Others

9.By Distribution Channel

• 9.1.Introduction
  • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.1.2.Market Attractiveness Index, By Distribution Channel
• 9.2.Hypermarkets/Supermarkets*
  • 9.2.1.Introduction
  • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3.Drug Stores & Pharmacies
• 9.4.E-Commerce
• 9.5.Others

10.By Region

• 10.1.Introduction
  • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2.Market Attractiveness Index, By Region
• 10.2.North America
  • 10.2.1.Introduction
  • 10.2.2.Key Region-Specific Dynamics
  • 10.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 10.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 10.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1.U.S.
    • 10.2.6.2.Canada
    • 10.2.6.3.Mexico
• 10.3.Europe
  • 10.3.1.Introduction
  • 10.3.2.Key Region-Specific Dynamics
  • 10.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 10.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 10.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1.Germany
    • 10.3.6.2.UK
    • 10.3.6.3.France
    • 10.3.6.4.Italy
    • 10.3.6.5.Russia
    • 10.3.6.6.Rest of Europe
• 10.4.South America
  • 10.4.1.Introduction
  • 10.4.2.Key Region-Specific Dynamics
  • 10.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 10.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 10.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1.Brazil
    • 10.4.6.2.Argentina
    • 10.4.6.3.Rest of South America
• 10.5.Asia-Pacific
  • 10.5.1.Introduction
  • 10.5.2.Key Region-Specific Dynamics
  • 10.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 10.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 10.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1.China
    • 10.5.6.2.India
    • 10.5.6.3.Japan
    • 10.5.6.4.Australia
    • 10.5.6.5.Rest of Asia-Pacific
• 10.6.Middle East and Africa
  • 10.6.1.Introduction
  • 10.6.2.Key Region-Specific Dynamics
  • 10.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 10.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11.Competitive Landscape

• 11.1.Competitive Scenario
• 11.2.Market Positioning/Share Analysis
• 11.3.Mergers and Acquisitions Analysis

12.Company Profiles

• 12.1.NOW Health Group, Inc.*
  • 12.1.1.Company Overview
  • 12.1.2.Product Portfolio and Description
  • 12.1.3.Financial Overview
  • 12.1.4.Key Developments
• 12.2.Solgar Inc.
• 12.3.Swanson
• 12.4.Life Extension
• 12.5.GNC Holdings, LLC
• 12.6.Pure Encapsulations
• 12.7.Bluebonnet Nutrition
• 12.8.Douglas Laboratories
• 12.9.Jabs Biotech Pvt. Ltd.
• 12.10.21ST Century HealthCare, Inc.

LIST NOT EXHAUSTIVE

13.Appendix

• 13.1.About Us and Services
• 13.2.Contact Us